Georgetown Hematology/Oncology Fellowship (@georgetownhof) 's Twitter Profile
Georgetown Hematology/Oncology Fellowship

@georgetownhof

Official Twitter account of MedStar Georgetown University Hematology/Oncology Fellowship Program @LombardiCancer

ID: 1510053321586970627

linkhttps://medicine.georgetown.edu/divisions/hematology/hematology-education/hematology-fellowship/ calendar_today02-04-2022 00:36:50

188 Tweet

331 Followers

179 Following

Cure GI Cancers (@rueschcenter) 's Twitter Profile Photo

Register today to join us in person as we explore cutting-edge research into the biological basis, epidemiology, prevention, and survivorship care of early-onset (young adult) GI Cancers and provide vital information for clinicians and patients. Learn more bit.ly/Ruesch2023

Register today to join us in person as we explore cutting-edge research into the biological basis, epidemiology, prevention, and survivorship care of early-onset (young adult) GI Cancers and provide vital information for clinicians and patients. Learn more bit.ly/Ruesch2023
Chul Kim (@chulkimmd) 's Twitter Profile Photo

Had the pleasure of discussing all things considered regarding EGFR-mutant NSCLC with leading experts, Drs. Myung-Ju Ahn and Byoung Chul Cho Byoung Chul Cho, M.D., Ph.D., for the second special episode of Lung Cancer Considered in Korean! IASLC

Stephen V Liu, MD (@stephenvliu) 's Twitter Profile Photo

Liquid biopsy is evolving into an essential tool for management of lung cancer. In this episode of the IASLC podcast, I had a great conversation about where the field is and where it's going with experts Drs. Umberto Malapelle Elsa Anagnostou International Society of Liquid Biopsy iaslc.org/iaslc-news/lun…

Cure GI Cancers (@rueschcenter) 's Twitter Profile Photo

Join us on Feb 9th to discuss research presented during ASCO #GI24. John Marshall, Ruth He, MD, PhD, Benjamin Weinberg, MD, FACP, Marcus S. Noel, and Reetu Mukherji, MD will highlight the most compelling abstracts on Colorectal, Pancreatic, Liver, and Upper GI cancers. Register now: bit.ly/3tk2S2D

Join us on Feb 9th to discuss research presented during <a href="/ASCO/">ASCO</a> #GI24. <a href="/marshalj23/">John Marshall</a>, <a href="/RuthHe12/">Ruth He, MD, PhD</a>, <a href="/benweinbergmd/">Benjamin Weinberg, MD, FACP</a>, <a href="/mnoel3232/">Marcus S. Noel</a>, and <a href="/ReetuMukherjiMD/">Reetu Mukherji, MD</a> will highlight the most compelling abstracts on Colorectal, Pancreatic, Liver, and Upper GI cancers. Register now: bit.ly/3tk2S2D
Balazs Halmos (@balazshalmosmd) 's Twitter Profile Photo

🙏 Stephen V Liu, MD -outstanding work by Montefiore Health System chief hem/onc fellow Angelica D'Aiello, MD! Complex/rapidly evolving topic- maybe some of u will want to read our review covering ☑️biology ☑️key trials ☑️biomarkers ☑️case challenges before your next busy clinic- like neoadjuvantly?😉

🙏 <a href="/StephenVLiu/">Stephen V Liu, MD</a> -outstanding work by <a href="/MontefioreNYC/">Montefiore Health System</a> chief hem/onc fellow <a href="/DAielloMD/">Angelica D'Aiello, MD</a>!
Complex/rapidly evolving topic- maybe some of u will want to read our review covering 
☑️biology
☑️key trials
☑️biomarkers
☑️case challenges
before your next busy clinic- like neoadjuvantly?😉
Stephen V Liu, MD (@stephenvliu) 's Twitter Profile Photo

Dr. Chul Kim helps bring #TTLC24 up to date with the latest advances in thymic epithelial tumors (#TET, thymoma, thymic carcinoma). Some promise targeting XPO1. Immunotherapy has activity but also toxicity, esp in thymoma. Trop2 may be a good target (ADC trial opening soon).

Dr. <a href="/chulkimMD/">Chul Kim</a> helps bring #TTLC24 up to date with the latest advances in thymic epithelial tumors (#TET, thymoma, thymic carcinoma). Some promise targeting XPO1. Immunotherapy has activity but also toxicity, esp in thymoma. Trop2 may be a good target (ADC trial opening soon).
Chul Kim (@chulkimmd) 's Twitter Profile Photo

With my mentee, Dr. Vanya Aggarwal, a 2nd-year fellow at Georgetown Hematology/Oncology Fellowship Georgetown Lombardi. Congratulations on receiving the Travel Award for #TTLC24. It’s a well-deserved honor. I am fortunate to work with Dr. Aggarwal.

With my mentee, Dr. Vanya Aggarwal, a 2nd-year fellow at <a href="/GeorgetownHOF/">Georgetown Hematology/Oncology Fellowship</a> <a href="/LombardiCancer/">Georgetown Lombardi</a>. Congratulations on receiving the Travel Award for #TTLC24. It’s a well-deserved honor. I am fortunate to work with Dr. Aggarwal.
Joshua Reuss (@joshua_reuss) 's Twitter Profile Photo

Dr. Jennifer A. Marks, MD breaks down latest data for Trastuzumab Deruxtecan in HER2-overexpressing solid tumors including NSCLC at #LungCancerSymposium. Rapidly evolving space & need more prospective data to ID pts most likely to respond such as concurrent HER2 amp. Georgetown Lombardi

Dr. <a href="/jennifermarksmd/">Jennifer A. Marks, MD</a> breaks down latest data for Trastuzumab Deruxtecan in HER2-overexpressing solid tumors including NSCLC at #LungCancerSymposium. Rapidly evolving space &amp; need more prospective data to ID pts most likely to respond such as concurrent HER2 amp. <a href="/LombardiCancer/">Georgetown Lombardi</a>
Narjust Florez, MD, FASCO (@narjustflorezmd) 's Twitter Profile Photo

Amazing discussion with Oncology Brothers with the next generation of thoracic medical oncologists at the OncLive.com Fellows Forum at #ASCO24 Best way to start ASCO thanks Dr. LudaBazhenovaMD for organizing this amazing event.

Amazing discussion with <a href="/OncBrothers/">Oncology Brothers</a> with the next generation of thoracic medical oncologists at the <a href="/OncLive/">OncLive.com</a> Fellows Forum at #ASCO24 

Best way to start <a href="/ASCO/">ASCO</a> thanks Dr. <a href="/LudaBazhenovaMD/">LudaBazhenovaMD</a> for organizing this amazing event.